External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Bex, Axel
van Werkhoven, Erik D.
Noe, Allard
Karam, Jose A.
Matin, Surena F.
Margulis, Vitaly
Stewart, Grant
Staehler, Michael D.
Wood, Christopher G.
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Munich, Dept Urol, Univ Hosp Munich Grosshadern, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
556
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Zini, L.
    Capitanio, U.
    Perrotte, P., I
    Jeldres, C.
    Isbarn, H.
    Shariat, S. F.
    Arjane, P., I
    Widmer, H.
    Briganti, A.
    Gallina, A.
    Suardi, N.
    Patard, J.
    Montorsi, F.
    Karakiewicz, P., I
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 180 - 180
  • [32] SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Zini, Laurent
    Capitanio, Umberto
    Perrotte, Paul
    Jeldres, Claudio
    Shariat, Shahrokh F.
    Arjane, Philippe
    Widmer, Hugues
    Briganti, Alberto
    Gallina, Andrea
    Suardi, Nazareno
    Patard, Jean-Jacques
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2009, 181 (04) : 497 - 497
  • [33] REGRESSION OF METASTATIC RENAL-CELL CARCINOMA AFTER CYTOREDUCTIVE NEPHRECTOMY
    MARCUS, SG
    CHOYKE, PL
    REITER, R
    JAFFE, GS
    ALEXANDER, RB
    LINEHAN, WM
    ROSENBERG, SA
    WALTHER, MM
    JOURNAL OF UROLOGY, 1993, 150 (02) : 463 - 466
  • [34] Metastatic Papillary Renal Cell Carcinoma Regression After Cytoreductive Nephrectomy
    Williams, Travis
    Rodriguez, Robert
    Murray, Katie
    Kovaleski, Aaron
    Madan, Rashna
    Van Veldhuizen, Peter
    UROLOGY, 2015, 85 (02) : 283 - 287
  • [35] Long survival (SV) for metastatic renal cell cancer (mRCC) after cytoreductive nephrectomy (CN) plus lung metastasectomy (LM) without targeted therapy (TT)
    Corona-Cruz, Jose F.
    Salvador, Miguel Patricio Moscoso-Fernandez
    Ramirez-Tirado, Laura Alejandra
    Gonzalez-Luna, Josue Andres
    Alvarez, Miguel A.
    Jimenez-Rios, Miguel Angel
    Lopez Saucedo, Raul Alejandro
    Jimenez-Fuentes, Edgardo
    Arrieta Rodriguez, Oscar Gerardo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study
    Okita, Kazutaka
    Hatakeyama, Shingo
    Naito, Sei
    Numakura, Kazuyuki
    Kato, Renpei
    Koguchi, Tomoyuki
    Kojima, Takahiro
    Kawasaki, Yoshihide
    Kandori, Shuya
    Kawamura, Sadafumi
    Nishiyama, Hiroyuki
    Ito, Akihiro
    Kojima, Yoshiyuki
    Habuchi, Tomonori
    Obara, Wataru
    Tsuchiya, Norihiko
    Ohyama, Chikara
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 836.e11 - 836.e17
  • [37] TIMING OF CYTOREDUCTIVE NEPHRECTOMY DOES NOT INFLUENCE SURVIVAL IN METASTATIC RENAL CELL CARCINOMA
    Chapin, Brian F.
    Delacroix, Scott E.
    Culp, Stephen H.
    Nogueras-Gonzalez, Graciela M.
    Tannir, Nizar
    Jonasch, Eric
    Tamboli, Pheroz
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2011, 185 (04) : E705 - E706
  • [38] Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).
    Cunha, Mateus Trinconi
    Stangler, Lucas
    Freire, Pedro
    Alves Pinto, Paulo Victor
    Almeida Coelho, Fernando Morbeck
    Viana, Publio
    Cordeiro, Mauricio
    Nahas, William Carlos
    Mota, Jose Mauricio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [39] DEVELOPMENT OF ACCURATE MODELS FOR INDIVIDUALIZED PREDICTION OF SURVIVAL AT 6 AND 12 MONTHS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA
    Margulis, Vitaly
    Shariat, Shahrokh
    Rink, Michael
    Sjoberg, Dan
    Jonasch, Eric
    Tamboli, Pheroze
    Vickers, Andrew
    Wood, Christopher
    JOURNAL OF UROLOGY, 2012, 187 (04) : E728 - E728
  • [40] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma CON
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 190 (02) : 386 - 386
12345